UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 48

Sortiert nach

Development of PARP and Immune-Checkpoint Inhibitor Combinations

Cancer research (Chicago, Ill.), 2018-12, Vol.78 (24), p.6717-6725

2018

Volltextzugriff (PDF)

Replication Stress Drives Constitutive Activation of the DNA Damage Response and Radioresistance in Glioblastoma Stem-like Cells

Cancer research (Chicago, Ill.), 2018-09, Vol.78 (17), p.5060-5071

2018

Volltextzugriff (PDF)

New Perspectives, Opportunities, and Challenges in Exploring the Human Protein Kinome

Cancer research (Chicago, Ill.), 2018-01, Vol.78 (1), p.15-29

2018

Volltextzugriff (PDF)

Restraining Network Response to Targeted Cancer Therapies Improves Efficacy and Reduces Cellular Resistance

Cancer research (Chicago, Ill.), 2018-08, Vol.78 (15), p.4344-4359

2018

Volltextzugriff (PDF)

An Immunogenic Model of KRAS-Mutant Lung Cancer Enables Evaluation of Targeted Therapy and Immunotherapy Combinations

Cancer research (Chicago, Ill.), 2022-10, Vol.82 (19), p.3435-3448

2022

Volltextzugriff (PDF)

Oxygen-Enhanced MRI Accurately Identifies, Quantifies, and Maps Tumor Hypoxia in Preclinical Cancer Models

Cancer research (Chicago, Ill.), 2016-02, Vol.76 (4), p.787-795

2016

Volltextzugriff (PDF)

Selective Inhibition of Parallel DNA Damage Response Pathways Optimizes Radiosensitization of Glioblastoma Stem-like Cells

Cancer research (Chicago, Ill.), 2015-10, Vol.75 (20), p.4416-4428

2015

Volltextzugriff (PDF)

TWIST1-WDR5- Hottip Regulates Hoxa9 Chromatin to Facilitate Prostate Cancer Metastasis

Cancer research (Chicago, Ill.), 2017-06, Vol.77 (12), p.3181-3193

2017

Volltextzugriff (PDF)

MetMAb, the one-armed 5D5 anti-c-Met antibody, inhibits orthotopic pancreatic tumor growth and improves survival

Cancer research (Chicago, Ill.), 2008-06, Vol.68 (11), p.4360-4368

2008

Volltextzugriff (PDF)

Identification of a novel estrogen response element in the Breast Cancer Resistance Protein (ABCG2) gene

Cancer research (Chicago, Ill.), 2004-02, Vol.64 (4), p.1247-1251

2004

Volltextzugriff (PDF)

Increased expression of genes converting adrenal androgens to testosterone in androgen-independent prostate cancer

Cancer research (Chicago, Ill.), 2006-03, Vol.66 (5), p.2815-2825

2006

Volltextzugriff (PDF)

Androgens induce prostate cancer cell proliferation through mammalian target of rapamycin activation and post- transcriptional increases in cyclin D proteins

Cancer research (Chicago, Ill.), 2006-08, Vol.66 (15), p.7783-7792

2006

Volltextzugriff (PDF)

Antagonizing Integrin β3 Increases Immunosuppression in Cancer

Cancer research (Chicago, Ill.), 2016-06, Vol.76 (12), p.3484-3495

2016

Volltextzugriff (PDF)

Epidermal Growth Factor Receptor and Mutant p53 Expand an Esophageal Cellular Subpopulation Capable of Epithelial-to-Mesenchymal Transition through ZEB Transcription Factors

Cancer research (Chicago, Ill.), 2010-05, Vol.70 (10), p.4174-4184

2010

Volltextzugriff (PDF)

The Kynurenine Pathway in Brain Tumor Pathogenesis

Cancer research (Chicago, Ill.), 2012-11, Vol.72 (22), p.5649-5657

2012

Volltextzugriff (PDF)

STAT3/PIAS3 Levels Serve as "Early Signature" Genes in the Development of High-Grade Serous Carcinoma from the Fallopian Tube

Cancer research (Chicago, Ill.), 2018-04, Vol.78 (7), p.1739-1750

2018

Volltextzugriff (PDF)

Formation of 17-allylamino-demethoxygeldanamycin (17-AAG) hydroquinone by NAD(P)h:quinone oxidoreductase 1 Role of 17-AAG hydroquinone in heat shock protein 90 inhibition

Cancer research (Chicago, Ill.), 2005-11, Vol.65 (21), p.10006-10015

2005

Volltextzugriff (PDF)

Cross-Cancer Genome-Wide Analysis of Lung, Ovary, Breast, Prostate, and Colorectal Cancer Reveals Novel Pleiotropic Associations

Cancer research (Chicago, Ill.), 2016-09, Vol.76 (17), p.5103-5114

2016

Volltextzugriff (PDF)

Kinetic analysis of epidermal growth factor receptor somatic mutant proteins shows increased sensitivity to the epidermal growth factor receptor tyrosine kinase inhibitor, erlotinib

Cancer research (Chicago, Ill.), 2006-08, Vol.66 (16), p.8163-8171

2006

Volltextzugriff (PDF)

Genomic Profiling of a Large Set of Diverse Pediatric Cancers Identifies Known and Novel Mutations across Tumor Spectra

Cancer research (Chicago, Ill.), 2017-01, Vol.77 (2), p.509-519

2017

Volltextzugriff (PDF)

Differing Src Signaling Levels Have Distinct Outcomes in Drosophila

Cancer research (Chicago, Ill.), 2007-11, Vol.67 (21), p.10278-10285

2007

Volltextzugriff (PDF)

Characterization of Gene―Environment Interactions for Colorectal Cancer Susceptibility Loci

Cancer research (Chicago, Ill.), 2012-04, Vol.72 (8), p.2036-2044

2012

Volltextzugriff (PDF)

hnRNP A2 regulates alternative mRNA splicing of TP53INP2 to control invasive cell migration

Cancer research (Chicago, Ill.), 2009-12, Vol.69 (24), p.9219-9227

2009

Volltextzugriff (PDF)

Novel 5' untranslated region variants of BCRP mRNA are differentially expressed in drug-selected cancer cells and in normal human tissues : Implications for drug resistance, tissue-specific expression, and alternative promoter usage

Cancer research (Chicago, Ill.), 2006-05, Vol.66 (10), p.5007-5011

2006

Volltextzugriff (PDF)

Novel MEK1 mutation identified by mutational analysis of epidermal growth factor receptor signaling pathway genes in lung adenocarcinoma

Cancer research (Chicago, Ill.), 2008-07, Vol.68 (14), p.5524-5528

2008

Volltextzugriff (PDF)

1 – 25 von 48

Suche als RSS-Feed

Aktive Filter

Zeitschrift / SerieCancer Research

SpracheJapanisch

Nur zeigenGeprüft (Peer-Review)

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Mit Volltextzugriff
(48)

Publikationsform

Artikel
(48)

Sprache

Englisch
(48)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Kollektion

Zeitschrift / Serie

Tumor Biology
(1)

Menü

Weitere Dienste

Einstellungen

Development of PARP and Immune-Checkpoint Inhibitor Combinations

Replication Stress Drives Constitutive Activation of the DNA Damage Response and Radioresistance in Glioblastoma Stem-like Cells

New Perspectives, Opportunities, and Challenges in Exploring the Human Protein Kinome

Restraining Network Response to Targeted Cancer Therapies Improves Efficacy and Reduces Cellular Resistance

An Immunogenic Model of KRAS-Mutant Lung Cancer Enables Evaluation of Targeted Therapy and Immunotherapy Combinations

Oxygen-Enhanced MRI Accurately Identifies, Quantifies, and Maps Tumor Hypoxia in Preclinical Cancer Models

Selective Inhibition of Parallel DNA Damage Response Pathways Optimizes Radiosensitization of Glioblastoma Stem-like Cells

TWIST1-WDR5- Hottip Regulates Hoxa9 Chromatin to Facilitate Prostate Cancer Metastasis

MetMAb, the one-armed 5D5 anti-c-Met antibody, inhibits orthotopic pancreatic tumor growth and improves survival

Identification of a novel estrogen response element in the Breast Cancer Resistance Protein (ABCG2) gene

Increased expression of genes converting adrenal androgens to testosterone in androgen-independent prostate cancer

Androgens induce prostate cancer cell proliferation through mammalian target of rapamycin activation and post- transcriptional increases in cyclin D proteins

Antagonizing Integrin β3 Increases Immunosuppression in Cancer

Epidermal Growth Factor Receptor and Mutant p53 Expand an Esophageal Cellular Subpopulation Capable of Epithelial-to-Mesenchymal Transition through ZEB Transcription Factors

The Kynurenine Pathway in Brain Tumor Pathogenesis

STAT3/PIAS3 Levels Serve as "Early Signature" Genes in the Development of High-Grade Serous Carcinoma from the Fallopian Tube

Formation of 17-allylamino-demethoxygeldanamycin (17-AAG) hydroquinone by NAD(P)h:quinone oxidoreductase 1 Role of 17-AAG hydroquinone in heat shock protein 90 inhibition

Cross-Cancer Genome-Wide Analysis of Lung, Ovary, Breast, Prostate, and Colorectal Cancer Reveals Novel Pleiotropic Associations

Kinetic analysis of epidermal growth factor receptor somatic mutant proteins shows increased sensitivity to the epidermal growth factor receptor tyrosine kinase inhibitor, erlotinib

Genomic Profiling of a Large Set of Diverse Pediatric Cancers Identifies Known and Novel Mutations across Tumor Spectra

Differing Src Signaling Levels Have Distinct Outcomes in Drosophila

Characterization of Gene―Environment Interactions for Colorectal Cancer Susceptibility Loci

hnRNP A2 regulates alternative mRNA splicing of TP53INP2 to control invasive cell migration

Novel 5' untranslated region variants of BCRP mRNA are differentially expressed in drug-selected cancer cells and in normal human tissues : Implications for drug resistance, tissue-specific expression, and alternative promoter usage

Novel MEK1 mutation identified by mutational analysis of epidermal growth factor receptor signaling pathway genes in lung adenocarcinoma

Aktive Filter

Suchergebnisse filtern